1. Home
  2. CYTK vs INSP Comparison

CYTK vs INSP Comparison

Compare CYTK & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • INSP
  • Stock Information
  • Founded
  • CYTK 1997
  • INSP 2007
  • Country
  • CYTK United States
  • INSP United States
  • Employees
  • CYTK 564
  • INSP N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • INSP Medical/Dental Instruments
  • Sector
  • CYTK Health Care
  • INSP Health Care
  • Exchange
  • CYTK Nasdaq
  • INSP Nasdaq
  • Market Cap
  • CYTK 5.8B
  • INSP 5.6B
  • IPO Year
  • CYTK 2004
  • INSP 2018
  • Fundamental
  • Price
  • CYTK $48.87
  • INSP $187.83
  • Analyst Decision
  • CYTK Buy
  • INSP Buy
  • Analyst Count
  • CYTK 16
  • INSP 11
  • Target Price
  • CYTK $84.07
  • INSP $232.55
  • AVG Volume (30 Days)
  • CYTK 1.2M
  • INSP 461.9K
  • Earning Date
  • CYTK 11-06-2024
  • INSP 02-04-2025
  • Dividend Yield
  • CYTK N/A
  • INSP N/A
  • EPS Growth
  • CYTK N/A
  • INSP N/A
  • EPS
  • CYTK N/A
  • INSP 1.09
  • Revenue
  • CYTK $3,219,000.00
  • INSP $755,594,000.00
  • Revenue This Year
  • CYTK N/A
  • INSP $29.96
  • Revenue Next Year
  • CYTK $795.25
  • INSP $19.52
  • P/E Ratio
  • CYTK N/A
  • INSP $171.71
  • Revenue Growth
  • CYTK N/A
  • INSP 32.52
  • 52 Week Low
  • CYTK $43.21
  • INSP $123.00
  • 52 Week High
  • CYTK $110.25
  • INSP $257.40
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 44.62
  • INSP 47.35
  • Support Level
  • CYTK $45.66
  • INSP $181.85
  • Resistance Level
  • CYTK $49.40
  • INSP $198.33
  • Average True Range (ATR)
  • CYTK 1.71
  • INSP 7.37
  • MACD
  • CYTK -0.20
  • INSP -0.22
  • Stochastic Oscillator
  • CYTK 50.79
  • INSP 36.29

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Share on Social Networks: